|
[1] Lee RC, Feinbaum RL, Ambros V.The C elegans heterochronicgene lin-4 encodes small RNAs with antisense complementarity tolin-14[J].Cell, 1993, 75 (5) :843-854.
|
|
[2]Nilsen TW.Mechanisms of microRNA-mediated gene regulation in ani-mal cells[J].Trends Genet, 2007, 23 (5) :243-249.
|
|
[3]Lewis BP, Burge CB, Bartel DP.Conserved seed pairing, often flankedby adenosines, indicates that thousands of human genes are microRNAtargets[J].Cell, 2005, 120 (1) :15-20.
|
|
[4]Calin GA, Croce CM.MicroRNA signatures in human cancers[J].Nat Rev Cancer, 2006, 6 (11) :857-866.
|
|
[5] Sayed D, Abdellatif M.MicroRNAs in development and disease[J].Physiol Rev, 2011, 91 (3) :827-887.
|
|
[6]Cao CY, Sun FL.MicroRNAs and tumor[J].Chin Med Herald, 2012, 9 (14) :12-14. (in Chinese) 曹长运, 孙凤林.MicroRNA和肿瘤[J].中国医药导报, 2012, 9 (14) :12-14.
|
|
[7]Wang L, Xu Y.MicroRNAs-the important participant in oncogen-esis[J].Chin Med Herald, 2012, 9 (6) :15-17. (in Chinese) 王玲, 徐艳.MicroRNAs (miRNAs) -肿瘤形成过程中的重要参与者[J].中国医药导报, 2012, 9 (6) :15-17.
|
|
[8]Friedman SL.Mechanisms of hepatic fibrogenesis[J].Gastroenter-ology, 2008, 134 (6) :1655-1669.
|
|
[9]Chau BN, Brenner DA.What goes up must come down:the emer-ging role of microRNA in fibrosis[J].Hepatology, 2011, 53 (1) :4-6.
|
|
[10]Lorenzen JM, Haller H, Thum T.MicroRNAs as mediators andtherapeutic targets in chronic kidney disease[J].Nat Rev Nephrol, 2011, 7 (5) :286-294.
|
|
[11]Van Rooji E, Olson EN.Searching for MIR-acles in cardiac fibro-sis[J].Circ Res, 2009, 104 (2) :138-140.
|
|
[12]Friedman SL.Liver fibrosis–from bench to bedside[J].J Hepa-tol, 2003, 38 (Suppl 1) :38-53.
|
|
[13] Bataller R, Brenner DA.Liver fibrosis[J].J Clin Invest, 2005, 115 (2) :209-218.
|
|
[14]Henderson NC, Iredale JP.Liver fibrosis:cellular mechanisms of pro-gression and resolution[J].Clinical Science, 2007, 112 (5) :265-280.
|
|
[15]Lee UE, Friedman SL.Mechanisms of hepatic fibrogenesis[J].BestPract Res Clin Gastroenterol, 2011, 25 (2) :195-206.
|
|
[16]Bataller R, Brenner DA.Liver fibrosis[J].J Clin Invest, 2005, 115 (2) :209-218.
|
|
[17]Atzori L, Poli G, Perra A.Hepatic stellate cell:A star cell in the liver[J].Int J Biochem Cell B, 2009, 41 (8-9) :1639-1642.
|
|
[18]Venugopal SK, Jiang J, Kim TH, et al.Liver fibrosis causes down-regulation of miRNA-150 and miRNA-194 in hepatic stellatecells, and their overexpression causes decreased stellate cell activa-tion[J].Am J Physiol Gastrointest Liver Physiol, 2010, 298 (1) :G101-106.
|
|
[19]Creighton C, Murakami Y, Toyoda H, et al.The progression of liv-er fibrosis is related with overexpression of the miR-199 and 200Families[J].PLoS ONE, 2011, 6 (1) :e16081.
|
|
[20]Ogawa T, Enomoto M, Fujii H, et al.MicroRNA-221/222 upregulationindicates the activation of stellate cells and the progression of liver fibrosis[J].Gut, 2012, 61 (11) :1600-1609.
|
|
[21]Cheung O, Puri P, Eicken C, et al.Nonalcoholic steatohepatitis isassociated with altered hepatic MicroRNA expression[J].Hepatolo-gy, 2008, 48 (6) :1810-1820.
|
|
[22]Jin X, Ye YF, Chen S, et al.MicroRNA expression pattern in dif-ferent stages of nonalcoholic fatty liver disease[J].Digest LiverDis, 2009, 41 (4) :289-297.
|
|
[23]Li S, Chen X, Zhang H, et al.Differential expression of microR-NAs in mouse liver under aberrant energy metabolic status[J].JLipid Res, 2009, 50 (9) :1756-1765.
|
|
[24]Alisi A, Da Sacco L, Bruscalupi G, et al.Mirnome analysis revealsnovel molecular determinants in the pathogenesis of diet-inducednonalcoholic fatty liver disease[J].Lab Invest, 2011, 91 (2) :283-293.
|
|
[25]Ji J, Zhang J, Huang G, et al.Over-expressed microRNA-27aand 27b influence fat accumulation and cell proliferation during rathepatic stellate cell activation[J].FEBS Letters, 2009, 583 (4) :759-766.
|
|
[26]Dolganiuc A, Petrasek J, Kodys K, et al.MicroRNA expressionprofile in Lieber-DeCarli diet-induced alcoholic and methioninecholine deficient diet-Induced nonalcoholic steatohepatitis modelsin mice[J].Alcohol Clin Exp Res, 2009, 33 (10) :1704-1710.
|
|
[27]Mengshol JA, Golden-Mason L, Rosen HR.Mechanisms of dis-ease:HCV-induced liver injury[J].Nat Clin Pract GastroenterolHepatol, 2007, 4 (11) :622-634.
|
|
[28]Ura S, Honda M, Yamashita T, et al.Differential microRNA ex-pression between hepatitis B and hepatitis C leading disease progres-sion to hepatocellular carcinoma[J].Hepatology, 2009, 49 (4) :1098-1112.
|
|
[29]Bala S.Emerging role of microRNAs in liver diseases[J].World JGastroenterol, 2009, 15 (45) :5633-5640.
|
|
[30]Hu XL, Fan GR.Functional role of microRNAs in viral hepatitis in-fection[J].J Clin Hepatol, 2012, 28 (11) :877-880 (in Chi-nese) 胡学玲, 范公忍.microRNA在乙型、丙型肝炎中的作用[J].临床肝胆病杂志, 2012, 28 (11) :877-880.
|
|
[31]Liu Y, Zhao JJ, Wang CM.Altered expression profiles of microR-NAs in a stable hepatitis B virus-expressing cell line[J].ChinMed J, 2009, 122 (1) :10-14.
|
|
[32]Bandyopadhyay S, Friedman RC, Marquez RT, et al.Hepatitis Cvirus infection and hepatic stellate cell activation downregulate miR-29:miR-29 overexpression reduces hepatitis C viral abundancein culture[J].J infect Dis, 2011, 203 (12) :1753-1762.
|
|
[33]Pfeffer S, Baumert TF.Unravelling the importance of microRNAsduring hepatitis C virus infection in the human liver[J].J Hepatol, 2009, 51 (3) :606-609.
|
|
[34]Jopling CL, Yi M, Lancaster AM, et al.Modulation of hepatitis Cvirus RNA abundance by a liver-specific microRNA[J].Science, 2005, 309 (5740) :1577-1581.
|
|
[35]Hou W, Tian Q, Zheng J, et al.MicroRNA-196 represses Bach1protein and hepatitis C virus gene expression in human hepatomacells expressing hepatitis C viral proteins[J].Hepatology, 2010, 51 (5) :1494-1504.
|
DownLoad: